文献速递新生儿儿童感染

孕期新冠感染与母婴发病率及死亡率:INTERCOVID多国队列研究

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study.
PubMed 文献 · JAMA Pediatr · 2021-01-01

该多国队列研究纳入706例新冠孕妇与1424例无新冠孕妇,发现新冠孕妇的子痫前期、严重感染、ICU入住、孕产妇死亡、早产及新生儿严重并发症风险均显著升高,发热和呼吸困难与母婴严重并发症风险增加相关。

要点

  • 新冠孕妇的重度子痫前期/子痫、严重感染、ICU入住及孕产妇死亡风险显著高于无新冠孕妇。
  • 新冠孕妇的早产、医学指征早产及新生儿严重并发症风险显著增加。
  • 发热和呼吸困难与母婴严重并发症风险升高相关,无症状感染者仅孕产妇发病率及子痫前期风险略高。

核心结论

  • 孕期新冠感染与孕产妇严重发病率、死亡率及新生儿并发症的持续且显著增加相关。

研究设计与样本

  • 2020年3月至10月在18个国家43家机构开展的多国队列研究,纳入706例新冠孕妇和1424例无新冠孕妇,随访至出院。

主要发现

  • 新冠孕妇的子痫前期/子痫风险为RR 1.76(95%CI 1.27-2.43),严重感染为RR 3.38(95%CI 1.63-7.01)。
  • 新冠孕妇的ICU入住风险为RR 5.04(95%CI 3.13-8.10),孕产妇死亡风险为RR 22.3(95%CI 2.88-172)。
  • 新冠孕妇的早产风险为RR 1.59(95%CI 1.30-1.94),医学指征早产为RR 1.97(95%CI 1.56-2.51)。
  • 新冠孕妇的新生儿严重发病率指数为RR 2.66(95%CI 1.69-4.18),围产期严重发病和死亡指数为RR 2.14(95%CI 1.66-2.75)。
  • 发热和呼吸困难与孕产妇严重并发症(RR 2.56;95%CI 1.92-3.40)及新生儿并发症(RR 4.97;95%CI 2.11-11.69)风险增加相关。

关键数值与推荐

  • 无症状新冠孕妇仅孕产妇发病率(RR 1.24;95%CI 1.00-1.54)和子痫前期(RR 1.63;95%CI 1.01-2.63)风险仍较高。
  • 新冠检测阳性孕妇所生新生儿中54例(13%)检测阳性。
  • 剖宫产与新生儿检测阳性风险增加相关(RR 2.15;95%CI 1.18-3.91),母乳喂养未显示关联(RR 1.10;95%CI 0.66-1.85)。

临床怎么用

  • 临床应告知孕妇新冠感染可显著增加母婴严重并发症风险,并严格实施所有推荐的预防措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Detailed information about the association of COVID-19 with outcomes in pregnant individuals compared with not-infected pregnant individuals is much needed. OBJECTIVE: To evaluate the risks associated with COVID-19 in pregnancy on maternal and neonatal outcomes compared with not-infected, concomitant pregnant individuals. DESIGN, SETTING, AND PARTICIPANTS: In this cohort study that took place from March to October 2020, involving 43 institutions in 18 countries, 2 unmatched, consecutive, not-infected women were concomitantly enrolled immediately after each infected woman was identified, at any stage of pregnancy or delivery, and at the same level of care to minimize bias. Women and neonates were followed up until hospital discharge. EXPOSURES: COVID-19 in pregnancy determined by laboratory confirmation of COVID-19 and/or radiological pulmonary findings or 2 or more predefined COVID-19 symptoms. MAIN OUTCOMES AND MEASURES: The primary outcome measures were indices of (maternal and severe neonatal/perinatal) morbidity and mortality; the individual components of these indices were secondary outcomes. Models for these outcomes were adjusted for country, month entering study, maternal age, and history of morbidity. RESULTS: A total of 706 pregnant women with COVID-19 diagnosis and 1424 pregnant women without COVID-19 diagnosis were enrolled, all with broadly similar demographic characteristics (mean [SD] age, 30.2 [6.1] years). Overweight early in pregnancy occurred in 323 women (48.6%) with COVID-19 diagnosis and 554 women (40.2%) without. Women with COVID-19 diagnosis were at higher risk for preeclampsia/eclampsia (relative risk [RR], 1.76; 95% CI, 1.27-2.43), severe infections (RR, 3.38; 95% CI, 1.63-7.01), intensive care unit admission (RR, 5.04; 95% CI, 3.13-8.10), maternal mortality (RR, 22.3; 95% CI, 2.88-172), preterm birth (RR, 1.59; 95% CI, 1.30-1.94), medically indicated preterm birth (RR, 1.97; 95% CI, 1.56-2.51), severe neonatal morbidity index (RR, 2.66; 95% CI, 1.69-4.18), and severe perinatal morbidity and mortality index (RR, 2.14; 95% CI, 1.66-2.75). Fever and shortness of breath for any duration was associated with increased risk of severe maternal complications (RR, 2.56; 95% CI, 1.92-3.40) and neonatal complications (RR, 4.97; 95% CI, 2.11-11.69). Asymptomatic women with COVID-19 diagnosis remained at higher risk only for maternal morbidity (RR, 1.24; 95% CI, 1.00-1.54) and preeclampsia (RR, 1.63; 95% CI, 1.01-2.63). Among women who tested positive (98.1% by real-time polymerase chain reaction), 54 (13%) of their neonates tested positive. Cesarean delivery (RR, 2.15; 95% CI, 1.18-3.91) but not breastfeeding (RR, 1.10; 95% CI, 0.66-1.85) was associated with increased risk for neonatal test positivity. CONCLUSIONS AND RELEVANCE: In this multinational cohort study, COVID-19 in pregnancy was associated with consistent and substantial increases in severe maternal morbidity and mortality and neonatal complications when pregnant women with and without COVID-19 diagnosis were compared. The findings should alert pregnant individuals and clinicians to implement strictly all the recommended COVID-19 preventive measures.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Villar J, Ariff S, Gunier RB, et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021. PMID: 33885740. doi:10.1001/jamapediatrics.2021.1050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。